Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
GlobeNewswire, Inc.
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved...
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
GlobeNewswire, Inc.
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline.1 Detailed...
India’s RBI Holds Rates at 5.25 Percent, Slashes Growth Outlook
MENAFN
(MENAFN) India's central bank left its benchmark interest rate unchanged on Friday while simultaneously downgrading its growth projections and raising its inflation outlook, as climbing global energy costs and a weakening rupee cast a shadow over...
U.S., Latin America Bloc Slam Drug-Funded Plot to Topple Bolivia
MENAFN
(MENAFN) The United States and a dozen Latin American nations issued a forceful joint condemnation Friday, accusing drug traffickers and criminal networks of bankrolling a coordinated campaign to bring down Bolivia's democratically elected...
News Release – DOH Authorizes Reopening of Ohana Sub & Deli, Inc. After Being Closed for Multiple Food Safety Violations
Governor of State of Hawaii
STATE OF HAWAIʻI KA MOKU ʻĀINA O HAWAIʻI JOSH GREEN, M.D. GOVERNOR KE KIAʻĀINA DEPARTMENT OF HEALTH KA ʻOIHANA OLAKINO KENNETH S. FINK, M.D., MGA, MPH DIRECTOR KA LUNA HOʻOKELE DOH AUTHORIZES REOPENING OF OHANA SUB & DELI, INC. AFTER BEING CLOSED...
U.S. Military Reaffirms Commitment to Palauan Communities Amid Ongoing Construction Activities
DVIDS - Georgia
KOROR, Republic of Palau —U.S. Navy Rear Adm. Josh Lasky, commander, Joint Task Force-Micronesia re-affirmed the U.S. military’s commitment to the people of Palau during a visit to the country last week.
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories
GlobeNewswire, Inc.
Oliv18™ expands the 18 Series with a USDA and EU organic certified, 100% solvent-free, whole olive polyphenol formulation from the Moroccan Saharan desert Hydroxytyrosol — the key active in Oliv18™ — is the highest ORAC polyphenol A single 250 mg...
AMASS Brands Group Secures First U.S. Distribution Partner for AMASS Electrolyte Mixers
GlobeNewswire, Inc.
Great Lakes Wine & Spirits, One of the Midwest’s Most Established Distribution Networks, to Launch AMASS Electrolyte Mixers Across Michigan Partnership Establishes Initial Midwest Foothold as AMASS Executes Multi-Market Functional Beverage Rollout...
Village Farms Announces $15 Million Registered Direct Equity Investment from Leading U.S. Institutional Investors
GlobeNewswire, Inc.
Company believes investment by renowned global firms demonstrates increasing interest in the Company and industry ahead of further regulatory progress Investment enhances Company’s liquidity position after closing 1Q’26 with $55 million in cash...
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
GlobeNewswire, Inc.
Kennewick, WA, June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a company pioneering Precision Radionuclide Therapy™ (PRnT) with its innovative RadioGel® technology, today announced the submission of its Early Feasibility IDE...
Missouri Response to New World Screwworm Detection in U.S.
Missouri Department of Agriculture
(JEFFERSON CITY, Mo.) – The United States Department of Agriculture Animal and Plant Health Inspection Service (USDA-APHIS) has confirmed the presence of New World Screwworm (NWS) in the United States.
Chevalier du Grand Robert (CGR) Named #1 Bordeaux Wine Brand in the United States
EIN Presswire
The French brand's rise to #1 reflects a growing consumer preference for traditional winemaking, authenticity, and everyday value.
USDA Confirms Presence of New World Screwworm in the United States
Louisiana Department of Agriculture & Forestry
News By APHIS Press June 3, 2026 News article Animal Health Officials Working Quickly to Protect U.S. Livestock and Wildlife WASHINGTON, DC- JUNE 03, 2026 – The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service...
Attorney General James Wins Court Order Protecting Food Security and Agricultural Funding
New York Attorney General
NEW YORK – New York Attorney General Letitia James today released the following statement after a federal judge blocked the Trump administration from imposing vague, sweeping new conditions on U.S. Department of Agriculture (USDA) funding: "For...
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
GlobeNewswire, Inc.
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neurostimulation Patent covers transcranial...
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
GlobeNewswire, Inc.
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity and further expands Amneal’s differentiated...
Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis
GlobeNewswire, Inc.
NAPLES, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that the U.S. Food and Drug...
June Mayor's Highlights Newsletter
City and County of Honolulu - Hawaii
The City’s CORE program provides emergency care to homeless people all across Oʻahu. This is a digital version of Mayor Rick Blangiardi’s newsletter for June 2026. You can also view the PDF version of the newsletter here.
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
GlobeNewswire, Inc.
REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
GlobeNewswire, Inc.
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Supplemental New Drug Application (sNDA) resubmission seeks...
Sign up for:
American Food & Beverage Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.